Menu Back toSession-9-FDA-Focus-on-Enforcement

Advertising and Promotion Regulatory Affairs Conference


Session 9: FDA: Focus on Enforcement

    Session Chair(s)
      Wayne L. Pines

      Wayne L. Pines

      • President, Regulatory Services and Healthcare
      • APCO Worldwide Inc., United States
    This session will focus on FDA’s recent enforcement actions. Representatives from four FDA medical centers will dive deeply into specific recent enforcement actions, which will offer insights into the agency’s thought process on enforcement actions.
    Learning Objective : At the conclusion of this session, participants should be able to:
    • Describe the latest ad promo enforcement actions from four FDA medical centers
    • Identify FDA’s ad promo enforcement priorities
    • Outline how FDA approaches ad promo enforcement actions
    Speaker(s)
      Thomas J. Moskal, DVM

      Panelist

      Thomas J. Moskal, DVM

      • Veterinary Medical Officer
      • FDA/CVM, United States
      Lisa L. Stockbridge, PhD

      Panelist

      Lisa L. Stockbridge, PhD

      • Branch Chief, Advertising and Promotional Labeling Branch, OCBQ, CBER
      • FDA, United States
      Deborah A. Wolf, JD

      Panelist

      Deborah A. Wolf, JD

      • Regulatory Counsel, Office of Compliance, CDRH
      • FDA, United States
      Thomas W. Abrams, MBA

      Panelist

      Thomas W. Abrams, MBA

      • Director, Office of Prescription Drug Promotion, OMP, CDER
      • FDA, United States

Contact us